Extended Acknowledgements: Publication "Carbon Footprint of Package Leaflets - A Comparative Study on Greenhouse Gas Emissions of Paper-Based and Digital Package Leaflets for Pharmaceuticals"

This study was sponsored by Bundesverband der Arzneimittel-Hersteller e. V. (BAH), Bundesverband der Pharmazeutischen Industrie e. V (BPI), Verband forschender Arzneimittelhersteller e. V. (vfa) and Rote Liste Service GmbH.
We would like to thank all funders as well as all companies that have been supporting and actively contributing to make this research possible, especially those who took part in the workshop/discussions and interviews or direct communication to answer questions.

The following pharmaceutical companies kindly supported the study by contributing data from real-life operations (in alphabetical order):

AbbVie Deutschland GmbH & Co. KG, Amgen GmbH, AstraZeneca GmbH, Bayer, Biotest Pharma GmbH, CHEPLAPHARM Arzneimittel GmbH, Dr. FALK PHARMA GMBH, Dr. Pfleger Arzneimittel GmbH, Dr. Willmar Schwabe GmbH & Co. KG, GlaxoSmithKline GmbH & Co. KG, HERMES ARZNEIMITTEL GMBH, MEDICE Arzneimittel Pütter GmbH & Co. KG, Merck Healthcare KGaA, Merz Pharma GmbH & Co. KGaA, mibe GmbH Arzneimittel, MSD Sharp & Dohme GmbH, Norgine GmbH, Novartis Pharma GmbH, Novo Nordisk Pharma GmbH, Sandoz in Deutschland (Hexal AG, 1 A Pharma GmbH), Sanofi-Aventis Deutschland GmbH, Takeda Pharma Vertrieb GmbH & Co. KG and Wörwag Pharma GmbH & Co.KG.

A further six companies provided data as well but did not agree to be listed for reasons other than the study and the publications.

Further information: